MASSDEVICE ON CALL — Returning senate hopeful Scott Brown (R-N.H.) renewed his once-fervent call for repeal of the medical device tax, telling reporters during a tour of Gamma Medica that the levy is "just a money grab to fund Obamacare."
Brown this week toured imaging devices maker Gamma, where executives told him that the tax will prevent the company from hiring at least 2 new workers or investing in R&D this year. Brown, a former Massachusetts senator who announced his bid for New Hampshire earlier this month, called the tax "a job killer."
Brown is well-versed in the lingo of medtech tax opposition, having spent a lot of time stumping against the levy during his run in the senate. He put the issue front and center in his re-election campaign against opponent Elizabeth Warren, who won the seat in 2012.
During that campaign, Brown stormed through the Bay State’s medtech line-up, hitting 3 medical device makers in a single week to highlight his push to repeal tax. The message has been a winning strategy for him in the past, going back to his successful 2010 campaign for a senate seat long held by the late Sen. Edward Kennedy.
Top Medicare official Blum resigns
Center for Medicare & Medicaid Services principal deputy administrator Jonathan Blum is stepping down from the role on May 16, planning to "pursue new opportunities."
iPhone app lets diabetics self-test their vision
DigiSight Technologies’ SightBook mobile app lets patients with diabetes keep track of their own vision by self-testing, but a pilot run through UCLA found little health benefit from the practice.
Social media docs talk tips for successful engagement
A quartet of health-based social media gurus hosted an afternoon session at the ACC Scientific Sessions in Washington, D.C., offering tips and words of caution for anyone thinking of jumping into the fray.
Hologic hits 2 million milestone for NovaSure ablation
Hologic (NSDQ:HOLX) this week announced that it had treated its 2 millionth patient with the NovaSure global endometrial ablation system, a minimally invasive treatment for life-restricting menstrual periods.